|
|
|
|
|
Related Brands |
|
|
|
|
|
|
|
|
|
Related Categories
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diet and Nutritions > Homeopathic Remedies > Homeopathic Analgesics
|
Fluidjoint Joint Health Formula, Easy-to-Swallow Caplets - 60 Ea |
To enhance and support joint function. |
Usually Ships in 1 Business day. |
|
|
|
In Stock : |
Yes |
|
List Price : |
$26.12 |
|
Your Price : |
$20.90 |
|
|
|
|
Quantity : |
|
|
|
|
|
|
|
|
|
|
Description |
|
MANUFACTURER: PATENT HEALTH, LLC.
INDICATIONS:
- Fluidjoint Tablets enhance and support joint function.
- Significantly greater effect over Glucosamine in improving overall joint health. Fluidjoint Tablets Promotes flexibility for bending and stretching.
- Fluidjoint Joint Health Formula Clinical results show no unwanted side effects.
- Rapid Results.
- Doctor and Pharmacist recommended 2000mg Per Dose FLUIDjoint is a breakthrough formula that is clinically shown to enhance joint health.
- The main ingredients in FLUIDjoint are natural micro-proteins that are concentrated and extracted from organic sources. These concentrated proteins support your body's natural process for maintaining healthy joints. Continued use of FLUIDjoint enhances joint function for everyday activities.
- Results should be noticeable within 7-14 days of use and the benefits have been shown to increase with continued daily use. FLUIDjoint will support your active lifestyle and allow you to live life to the fullest.
- Hip, Finger, Shoulder, Elbow, Back, Knee, Wrist, Ankle, Neck, Toes. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
DIRECTIONS:
Do not skip a dose. Allow up to 14 days for the beneficial results of FLUIDjoint™. Take 2 FLUIDjoint Caplets twice daily. Take 2 in the morning and 2 in the evening. May be taken with food or drink.
|
|
|
|
Customer Rating |
   
|
Add Product Review |
|
Most Recent Reviews |
|
   
|
wife likes it much |
wife says she lives better WITH it |
-- jasper, OH, United States, 12/3/2008 |
|
|
|
|
|
|